CXCL10 and urogenital neoplasm: In a previous study on kidney transplant recipients [4], our group identified miR155-5p and interferon gamma inducible chemokine 10 (CXCL-10) as prognostic and diagnostic biomarkers of rejection based on a receiver operating characteristic (ROC) curve data analysis.